Haleon plc (FRA:H6D0)

Market Cap	37.79B -10.5%
Revenue (ttm)	12.64B -1.8%
Net Income	1.91B +15.6%
EPS	0.21 +17.8%
Shares Out	n/a
PE Ratio	19.78
Forward PE	17.96
Dividend	0.08 (1.92%)
Ex-Dividend Date	Aug 14, 2025

Volume	250
Average Volume	486
Open	4.155
Previous Close	4.197
Day's Range	4.125 - 4.210
52-Week Range	3.721 - 4.996
Beta	n/a
RSI	38.36
Earnings Date	Jul 30, 2026

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal dr...

• Industry: Pharmaceutical Preparations
• Founded: 1715
• Employees: 24,535
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: H6D0

Financial Performance

In 2025, Haleon's revenue was 11.03 billion, a decrease of -1.81% compared to the previous year's 11.23 billion. Earnings were 1.67 billion, an increase of 15.60%.

Financial numbers in GBP